This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Karssen, A. M. Articles by de Kloet, E. R. Search for Related Content PubMed PubMed Citation Articles by Karssen, A. M. Articles by de Kloet, E. R.

Low Doses of Dexamethasone Can Produce a Hypocorticosteroid State in the Brain

Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research and Leiden University Medical Center, 2300 RA Leiden, The Netherlands

Address all correspondence and requests for reprints to: E. R. de Kloet, Division of Medical Pharmacology, Leiden/Amsterdam Center for Drug Research, P.O. Box 9503, 2300 RA Leiden, The Netherlands. E-mail: e.kloet{at}lacdr.leidenuniv.nl.

The synthetic glucocorticoid dexamethasone (dex) blocks stress-induced hypothalamic-pituitary-adrenal (HPA) activation primarily at the level of the anterior pituitary because multidrug resistance P-glycoprotein hampers its penetration in the brain. Here, we tested the hypothesis that central components of the HPA axis would escape dex suppression under conditions of potent peripheral glucocorticoid action. We subchronically treated rats with low or high doses of dex. The animals were subjected on the last day of treatment for 30 min to a restraint stressor after which central and peripheral markers of HPA axis activity were measured. Basal and stress-induced corticosterone secretion, body weight gain, adrenal and thymus weight, as well as proopiomelanocortin mRNA in the anterior pituitary were reduced in a dose-dependent manner by dex administered either 5 d sc or 3 wk orally. In the brain, the highest dose dex suppressed CRH mRNA and CRH heteronuclear RNA in the paraventricular nucleus (PVN). However, in the peripherally active low-dose range of dex CRH mRNA and heteronuclear RNA showed resistance to suppression, and CRH mRNA expression in the PVN was in fact enhanced under the long-term treatment condition. In the PVN, c-fos mRNA was suppressed by the highest dose of dex, but this effect showed a degree of resistance after long-term oral treatment. c-fos mRNA responses in the anterior pituitary followed those in PVN and reflect central drive of the HPA axis even if corticosterone responses are strongly reduced. The results support the concept that low doses of dex can create a hypocorticoid state in the brain.

This article has been cited by other articles:

				S. A. McIsaac, A. Westrin, and A. H. Young Antiglucocorticoids in psychiatry Adv. Psychiatr. Treat., July 1, 2009; 15(4): 242 - 249. [Abstract] [Full Text] [PDF]

				M. V. Schmidt, V. Sterlemann, K. Wagner, B. Niederleitner, K. Ganea, C. Liebl, J. M. Deussing, S. Berger, G. Schutz, F. Holsboer, et al. Postnatal Glucocorticoid Excess Due to Pituitary Glucocorticoid Receptor Deficiency: Differential Short- and Long-Term Consequences Endocrinology, June 1, 2009; 150(6): 2709 - 2716. [Abstract] [Full Text] [PDF]

				S. Lachize, E. M. Apostolakis, S. van der Laan, A. M. I. Tijssen, J. Xu, E. R. de Kloet, and O. C. Meijer Steroid receptor coactivator-1 is necessary for regulation of corticotropin-releasing hormone by chronic stress and glucocorticoids PNAS, May 12, 2009; 106(19): 8038 - 8042. [Abstract] [Full Text] [PDF]

				B. L. Mason, C. M. Pariante, and S. A. Thomas A Revised Role for P-Glycoprotein in the Brain Distribution of Dexamethasone, Cortisol, and Corticosterone in Wild-Type and ABCB1A/B-Deficient Mice Endocrinology, October 1, 2008; 149(10): 5244 - 5253. [Abstract] [Full Text] [PDF]

				B. S. McEwen Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain Physiol Rev, July 1, 2007; 87(3): 873 - 904. [Abstract] [Full Text] [PDF]